Evaluation of Nephrotoxicity among Cervical and Ovarian Cancer Patients Treated with Cisplastin Based Chemotherapy at Tikur Anbessa Specialized Hospital Chemotherapy and Radiotherapy Center, Ethiopia

dc.contributor.advisorGirma Jigsa
dc.contributor.authorTefera Fasil
dc.date.accessioned2018-06-28T11:54:44Z
dc.date.accessioned2023-11-06T08:57:28Z
dc.date.available2018-06-28T11:54:44Z
dc.date.available2023-11-06T08:57:28Z
dc.date.issued2016-02
dc.description.abstractBackground: Cancer is potentially fatal diseases; it can be caused by mainly environmentalfactors that mutate genes encoding critical cell-regulatory proteins. Cisplatin is a potent and aneffective chemotherapeutic agent used to treat cervical and ovarian cancer, but is associated withthe risk of nephrotoxicity. The prevalence of cisplatin based chemotherapy inducednephrotoxicity was not assessed in Ethiopia. Objective: To assess the magnitudes of Cisplatin-based chemotherapy induced nephrotoxicityamong cervical and ovarian cancer patients underwent cisplatin treatment at the oncology unit ofTikur Anbessa Specialized Hospital (TASH). Materials and Methods: A prospective cross-sectional study has been conducted on 76 cervicaland ovarian cancer patients who received cisplatin based chemotherapy. Clinical and laboratorydata including kidney function tests were recorded at baseline and 21 days after treatment withcisplatin based chemotherapy. Serum creatinine, urea, uric acid and calcium have been analyzedusing automated clinical chemistry analyzer (Mindray02) and estimated creatinine clearance hasbeen calculated based on Cockcroft-Gault formula. Toxicities were classified according to thecommon toxicity criteria (CTC) scale set by (NCI CTC AE V4.0). Results: Serum creatinine, uric acid levels increased significantly during the 1 cycles ofchemotherapy, whereas eGFR levels decreased significantly. Accordingly, the results were(1.0854 ±0.781SD), (5.9 ±2.7SD) and (50.217±14.0SD) respectively where the (P. value 0.001),(p.value 0.00) and (p. value 0.00). On the other hand, serum urea and calcium levels showed nostatistical significant difference have been shown where (p. value>0.05). According to Pearson‟scorrelation analysis showed pre and post chemotherapy there was a strong negative correlationbetween the eGFR and serum creatinine level correspondingly (rho: –0.150 Vs -0.136, P <0.001), and Spearman‟s correlation analysis showed that there was a strong negative correlationbetween the eGFR and uric acid level after treatment (rho: –0.500, P < 0.05). Conclusion and Recommendation: Significant changes have been observed after the 1 cycle ofcisplatin based chemotherapy treatment on the levels of serum creatinine, uric acid levels anddecreased glomerular filtration rate. To effectively monitor nephrotoxicity, renal parameters andelectrolyte levels should be measured before and after each cisplatin based chemotherapy cycle.More investigations are required to evaluate this method with higher doses of cisplatin. Keywords: Cisplatin; 5Fluorouracil; Nephrotoxicity; chemotherapy; Tikur Anbessa SpecializedHospital en_US
dc.identifier.urihttp://etd.aau.edu.et/handle/123456789/4654
dc.language.isoenen_US
dc.publisherAddis Ababa Universityen_US
dc.subjectCisplatin 5FluorouracilNephrotoxicityChemotherapy;Tikur Anbessa Specialized Hospitalen_US
dc.titleEvaluation of Nephrotoxicity among Cervical and Ovarian Cancer Patients Treated with Cisplastin Based Chemotherapy at Tikur Anbessa Specialized Hospital Chemotherapy and Radiotherapy Center, Ethiopiaen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Fasil_Tefera_2016_ETD.pdf
Size:
784.25 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: